A drug used to treat malaria does not, after all, create new insulin-producing cells, according to a new paper published in Cell Metabolism, refutes a study published in Cell in January.
"First we had hoped that we would be able to replicate the findings, but they didn't hold up," said the senior author. "People with Type 1 diabetes, they see these stories come out and they think maybe there's something on the horizon and then nothing ever follows through," senior author said.
The symptoms of Type 1 and Type 2 diabetes are quite similar but the underlying causes differ. In type 1 diabetes, the body fails to create enough insulin, a hormone produced by the pancreas that regulates cellular intake of nutrients. In Type 2 diabetes, cells no longer respond efficiently to insulin.
Insulin is produced in hormone-producing regions of the pancreas called islets. Within the islets are alpha and beta cells. Beta cells are integral to creating insulin.
"That's the cell that if you lose (insulin production), you get Type 1 diabetes," said the senior author. So there is always interest in any process that might generate new beta cells to replace those lost in Type 1 diabetes.
In early 2017, in a paper published in the journal Cell, a European team reported that the antimalarial drug artemether could convert alpha cells into functional beta cells. While alpha cells converting into beta cells had been described before, this was the first time an existing drug had been reported to stimulate the process and it caused a lot of excitement in the field, senior author said.
Outfitted with the precision tools to capture alpha-to-beta cellular conversion, senior author enlisted graduate student to assist with replicating the original experiment.
"We were hoping, expecting, to confirm," senior author said. "We weren't able to."
The grad student used pancreatic islets derived from mice. After around four months of experiments with artemether, it was clear that the drug was not triggering alpha to beta cell conversion, as the initial Cell paper had claimed.
The Cell paper suggested that the widely used anti-malaria drug artemether suppresses the α cell transcription factor Arx to promote transdifferentiation into β cells. However, key initial experiments in this paper were carried out in islet cell lines, and most subsequent validation experiments implied transdifferentiation without direct demonstration of α to β cell conversion.
Indeed, the authors founnd no evidence that artemether promotes transdifferentiation of primary α cells into β cells. Moreover, artemether reduces Ins2 expression in primary β cells >100-fold, suppresses glucose uptake, and abrogates β cell calcium responses and insulin secretion in response to glucose.These observations suggest that artemether induces general islet endocrine cell dedifferentiation,
The new paper highlights the importance of reproducibility, a perennial and hotly contested topic of concern at all levels of scientific research. It also demonstrates how routine lab assignments meant to educate students can provide the foundations for published research.
"It's important to realize that our work has an impact in the real world," senior author said. "We should continuously strive to hold ourselves and our peers to a higher standard, particularly when we talk about discoveries that promise a possible cure for diabetes."
https://www.ucdavis.edu/news/study-refutes-using-anti-malaria-drug-treat-diabetes
http://www.cell.com/cell-metabolism/fulltext/S1550-4131(17)30614-9
Latest News
Circadian rhythms can influ…
By newseditor
Posted 27 Apr
With hybrid brains, these m…
By newseditor
Posted 27 Apr
Blocking activation of NF-κ…
By newseditor
Posted 27 Apr
Vitamin D regulates microbi…
By newseditor
Posted 27 Apr
Role of alternative splicin…
By newseditor
Posted 27 Apr
Other Top Stories
Blood ceramides link diet, diabetes and cardiovascular disease
Read more
How are proteins sorted and targeted in the cell?
Read more
How our bodies shift between making bones and breaking them down
Read more
Role of copper transporter in blood vessel growth
Read more
Distinct biological ages across individuals' various organs and sys…
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Single dose creatine improv…
By newseditor
Posted 27 Apr
Autonomous circadian rhythm…
By newseditor
Posted 27 Apr
Functional sensory circuits…
By newseditor
Posted 27 Apr
Positive selection CRISPR s…
By newseditor
Posted 27 Apr
Focal clusters of peri-syna…
By newseditor
Posted 27 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar